FrancophonIA/ELRC3.0 huggingface dataset:
English: Respiratory, thoracic, and mediastinal disorders Very common: Nasal congestion/rhinorrhoea Uncommon: Epistaxis
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora Zelo pogosti: zamašen nos/rinoreja Občasni: epistaksa
English: DO NOT INJECT FLUENZ.
Slovenian: CEPIVA FLUENZ NE INJICIRAJTE.
English: Please read the package leaflet for disposal of medicines no longer required.
Slovenian: Za odstranjevanje zdravil, ki jih več ne potrebujete, preberite navodilo za uporabo.
English: No clinically meaningful changes in immune responses to measles, mumps, varicella, orally-administered poliovirus or FLUENZ have been observed.
Slovenian: Klinično pomembnih sprememb odziva imunskega sistema na cepivo proti ošpicam, mumpsu, noricam in na peroralno cepivo proti otroški paralizi ali cepivo FLUENZ niso opazili.
English: If any of these apply, tell your doctor, nurse or pharmacist before vaccination.
Slovenian: Če karkoli od tega velja za vas, obvestite svojega zdravnika, medicinsko sestro ali farmacevta pred cepljenjem.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION FLUENZ
Slovenian: IME ZDRAVILA IN POT(I) UPORABE FLUENZ cepivo proti gripi
English: 6.6 Special precautions for disposal and other handling
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Uporaba cepiva
English: Efficacy (95% CI)b All strains regardless of match
Slovenian: Učinkovitost (95-% IZ)b Vsi sevi neodvisno od ujemanja
English: Do not administer FLUENZ to children and adolescents younger than 18 years of age receiving salicylate therapy (see section 4.3).
Slovenian: Cepiva FLUENZ se ne sme uporabiti pri otrocih in mladostnikih mlajših od 18 let, ki se zdravijo s salicilatom (glejte poglavje 4.3).
English: In a clinical study, an increase in hospitalisations was observed in infants and toddlers younger than 12 months after vaccination (see section 4.8).
Slovenian: V klinični študiji so po cepljenju opazili povečano stopnjo hospitalizacije pri dojenčkih in malčkih mlajših od 12 mesecev (glejte poglavje 4.8).
English: FLUENZ IS FOR NASAL USE ONLY.
Slovenian: CEPIVO FLUENZ JE SAMO ZA NAZALNO UPORABO.
English: FLUENZ is not indicated for use in infants and toddlers younger than 24 months (see section 4.4).
Slovenian: Cepivo FLUENZ ni indicirano za uporabo pri dojenčkih in malčkih mlajših od 24 mesecev (glejte poglavje 4.4).
English: Non-clinical data with FLUENZ reveal no special hazard for humans based on conventional non-clinical studies of repeated dose toxicity, reproduction and developmental toxicity, local tolerance, and neurovirulence.
Slovenian: Predklinični podatki s cepivom FLUENZ na osnovi običajnih študij predklinične varnosti, toksičnosti pri ponavljajočih se odmerkih, vpliva na sposobnost razmnoževanja in razvoja, lokalnega prenašanja in nevrovirulence ne kažejo posebnega tveganja za človeka.
English: Fluenz must not be injected.
Slovenian: Cepiva Fluenz se ne sme injicirati.
English: Efficacy (95% CI)
Slovenian: Učinkovitost (95-% IZ)
English: Contents of the pack and other information
Slovenian: Shranjevanje cepiva Fluenz Vsebina pakiranja in dodatne informacije
English: Fluenz will be given as a spray in each nostril.
Slovenian: Cepivo Fluenz se daje v obliki pršila v vsako nosnico.
English: No data exist regarding the safety of intranasal administration of FLUENZ in children with unrepaired craniofacial malformations.
Slovenian: O intranazalnem dajanju cepiva FLUENZ otrokom z nepopravljenimi kraniofacialnimi deformacijami ni podatkov.
English: • Refer to the FLUENZ administration diagram (Figure 1) for step-by-step administration instructions.
Slovenian: • Za navodila za aplikacijo cepiva FLUENZ po korakih glejte postopek aplikacije (slika 1).
English: - If you have any further questions, ask your doctor, nurse or pharmacist.
Slovenian: - Če imate dodatna vprašanja, se posvetujte s svojim zdravnikom, medicinsko sestro ali s farmacevtom.
English: Check expiry date Product must be used before date on applicator label.
Slovenian: Preverite rok uporabnosti Cepivo uporabite pred datumom na oznaki nosnika.
English: Very rare (may affect up to 1 in 1,000,000 people):
Slovenian: Zelo redki (pojavijo se pri največ 1 od 1.000.000 oseb):
English: Position the applicator With the patient in an upright position, place the tip just inside the nostril to ensure Fluenz is delivered into the nose.
Slovenian: Namestitev nosnika Ko je oseba v pokončnem položaju, namestite konico nekoliko v nosnico, da zagotovite vnos cepiva Fluenz v nos.
English: Contents of the pack and other information What Fluenz contains
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje cepivo Fluenz Zdravilne učinkovine so:
English: The suspension is a colourless to pale yellow liquid that is clear to slightly cloudy.
Slovenian: Suspenzija je brezbarvna do bledorumena, bistra do nekoliko motna tekočina.
English: In a clinical study, an increased rate of wheezing was observed in infants and toddlers 12-23 months of age after vaccination (see section 4.8).
Slovenian: V klinični študiji so po cepljenju opazili povečano stopnjo sopenja pri dojenčkih in malčkih starih od 12-23 mesecev (glejte poglavje 4.8).
English: Summary of adverse reactions
Slovenian: Povzetek neželenih učinkov
English: Tell your doctor straight away or seek urgent medical care if you experience any of the effects above.
Slovenian: Če opazite kateri koli zgoraj naštet neželeni učinek, nemudoma obvestite svojega zdravnika ali poiščite nujno medicinsko pomoč.
English: D153-P502 Europe c c
Slovenian: D153-P502 Evropa
English: Marketing Authorisation Holder: MedImmune, LLC, Lagelandseweg 78, 6545 CG Nijmegen, Netherlands, (Tel) +31 24 371 7310
Slovenian: MedImmune, LLC Lagelandseweg 78 6545 CG Nijmegen Nizozemska (tel) +31 24 371 7310
English: Talk to your doctor, nurse or pharmacist before vaccination:
Slovenian: Pred cepljenjem se posvetujte s svojim zdravnikom, medicinsko sestro ali farmacevtom:
English: Contains also: sucrose, dibasic potassium phosphate, monobasic potassium phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate, water for injections.
Slovenian: Vsebuje tudi: saharozo, kalijev hidrogenfosfat, kalijev dihidrogenfosfat, želatino (svinjsko, tipa A), argininijev klorid, natrijev glutamat monohidrat, vodo za injekcije.
English: Fluenz must only be used as a nasal spray.
Slovenian: Cepivo Fluenz se lahko uporablja le v obliki pršila za nos.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Reassortant influenza virus* (live attenuated) of the following strains**: A/California/7/2009 (H1N1)pdm09-like strain (A/California/7/2009, MEDI 228029)
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Novi virus gripe* (živ oslabljen) naslednjih sevov**: A/California/7/2009 (H1N1)pdm09-podoben sev (A/California/7/2009, MEDI 228029)
English: If any of these apply, tell your doctor, nurse or pharmacist.
Slovenian: Če karkoli od tega velja za vas, obvestite svojega zdravnika, medicinsko sestro ali farmacevta.
English: Efficacy (95% CI)b Matched strains
Slovenian: Učinkovitost (95-% IZ)b Ujemajoči se sevi
English: Reassortant influenza virus* (live attenuated) of the following strains**: A/California/7/2009 (H1N1)pdm09-like strain (A/California/7/2009, MEDI 228029)
Slovenian: Novi virus gripe* (živ oslabljen) naslednjih sevov**: A/California/7/2009 (H1N1)pdm09-podoben sev (A/California/7/2009, MEDI 228029)
English: Dibasic potassium phosphate Monobasic potassium phosphate Gelatin (porcine, Type A) Arginine hydrochloride Monosodium glutamate monohydrate Water for injections
Slovenian: 6.1 Seznam pomožnih snovi saharoza kalijev hidrogenfosfat kalijev dihidrogenfosfat želatina (svinjska, tip A) argininijev klorid natrijev glutamat monohidrat voda za injekcije
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS PACK SIZE OF 5 SINGLE-USE NASAL APPLICATORS
Slovenian: VELIKOST PAKIRANJA 5 NOSNIKOV ZA ENKRATNO UPORABO
English: - If any of the side effects gets serious, talk to your doctor, nurse or pharmacist.
Slovenian: - Če katerikoli neželeni učinek postane resen, se posvetujte s svojim zdravnikom, medicinsko sestro ali farmacevtom.
English: The other ingredients are sucrose, dibasic potassium phosphate, monobasic potassium phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate and water for injections.
Slovenian: Pomožne snovi so saharoza, kalijev hidrogenfosfat, kalijev dihidrogenfosfat, želatina (svinjska, tipa A), argininijev klorid, natrijev glutamat monohidrat in voda za injekcije.
English: The co-administration of FLUENZ with the live attenuated vaccines: measles, mumps, rubella, varicella, and orally-administered poliovirus has been studied.
Slovenian: Preučili so sočasno uporabo cepiva FLUENZ z živimi oslabljenimi cepivi proti ošpicam, mumpsu, rdečkam, noricam in peroralnim cepivom proti otroški paralizi.
English: AstraZeneca AS Tlf: +47 21 00 64 00
Slovenian: Tlf: +47 21 00 64 00
English: METHOD OF ADMINISTRATION For nasal use only.
Slovenian: POSTOPEK UPORABE Samo za nazalno uporabo.
English: fewer cases than injectable
Slovenian: manj primerov kot pri cepivu, ki se injicira d manj primerov kot pri cepivu, ki se injicira
English: STATEMENT OF ACTIVE SUBSTANCE(S) Reassortant influenza virus* (live attenuated) of the following strains**: A/California/7/2009 (H1N1)pdm09-like strain (A/California/7/2009, MEDI 228029)
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Novi virus gripe* (živ oslabljen) naslednjih sevov**: A/California/7/2009 (H1N1)pdm09-podoben sev (A/California/7/2009, MEDI 228029)
English: Fluenz nasal spray suspension Influenza vaccine (live attenuated, nasal)
Slovenian: FLUENZ pršilo za nos, suspenzija cepivo proti gripi (z živimi oslabljenimi virusi, nosno)
English: USA
Slovenian: Združene države Amerike (ZDA)
English: Method of administration Immunisation must be carried out by nasal administration.
Slovenian: Način uporabe Imunizacija se opravi z nazalno uporabo.
English: Nasal spray, suspension
Slovenian: FARMACEVTSKA OBLIKA pršilo za nos, suspenzija
English: Do not pass it on to others.
Slovenian: Napršite v drugo
English: 6 to 35 M 2,107
Slovenian: 6 do 35 m 1.616
English: D153-P513 Asia/ Oceania
Slovenian: D153-P513 Azija/ Oceanija 6 do 35 m 2.107
English: remove the dose-divider clip from plunger.
Slovenian: Odstranite sponko za razdelitev odmerka Za vnos v drugo nosnico odščipnite in odstranite sponko za razdelitev odmerka z bata.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SINGLE-USE NASAL APPLICATOR
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
English: Packaging Content Package size Withdrawal period
Slovenian: Vrsta ovojnine Vsebina Pakiranje Karenca
English: EU number Invented name
Slovenian: Izmišljeno ime
English: CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
Slovenian: POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO ZDRAVILA, KI JIH MORAJO VPELJATI DRŽAVE ČLANICE
English: ANNEX CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
Slovenian: PRILOGA POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO ZDRAVILA, KI JIH MORAJO VPELJATI DRŽAVE ČLANICE
English: ATCvet code: QM01AH90.
Slovenian: ATCvet oznaka: QM01AH90.
English: 4.6 Adverse reactions (frequency and seriousness)*
Slovenian: 4.6 Neželeni učinki (pogostost in resnost)*
English: Tablets can be administered with or without food.
Slovenian: Tablete lahko dajemo s hrano ali brez.
English: Date of first authorisation: 13/09/2004 Date of last renewal: 29/05/2009
Slovenian: Datum pridobitve dovoljenja za promet: 13.09.2004 Datum podaljšanja dovoljenja za promet: 29.05.2009
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Slovenian: Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu/
English: Peri-operative pain management.
Slovenian: Peri-operativno obvladovanje bolečine.
English: Firocoxib is approximately 96 % bound to plasma proteins.
Slovenian: Firokoksib se v približno 96 % veže na plazemske proteine.
English: 4 Chemin de Calquet 31000 Toulouse France
Slovenian: 4 chemin du Calquet 31000 TOULOUSE FRANCIJA
English: The elimination half-life (t½) is 7.59 (± 1.53) hours.
Slovenian: Razpolovna doba izločanja (t½) je 7,59 (± 1,53) ur.
English: Relief of post-operative pain:
Slovenian: Lajšanje post-operativne bolečine:
English: Iron oxides (E172) Caramel (E150d)
Slovenian: Železov oksid (E172) Karamel (E150d)
English: Osteoarthritis:
Slovenian: Osteoartritis:
English: Duration of treatment will be dependent on the response observed.
Slovenian: Čas trajanja zdravljenja je odvisen od odziva.
English: Very rare (affects less than 1 animal in 10,000)
Slovenian: Redki (prizadenejo 1 do 10 živali od 10.000 živali) Zelo redki (prizadenejo manj kot eno žival od 10.000 živali)
English: Overdose studies were not conducted in animals over 14 months of age.
Slovenian: Raziskave na psih starejših od 14 mesecev niso bile izvedene.
English: Manufacturer for the batch release: MERIAL, 4 Chemin du Calquet, 31000 Toulouse, France
Slovenian: Izdelovalec, odgovoren za sprostitev serije: MERIAL, 4 Chemin du Calquet, 31000 Toulouse, Francija
English: Firocoxib
Slovenian: Firokiksib
English: 10 tablets 30 tablets 60 tablets 180 tablets
Slovenian: 10 tablet 30 tablet 60 tablet 180 tablet
English: If such use cannot be avoided, those dogs require careful veterinary monitoring.
Slovenian: Če se uporabi v takih primerih ne moremo izogniti, je potreben strog veterinarski nadzor.
English: The chewable tablets (57 mg or 227 mg) are available in the following pack sizes:
Slovenian: Žvečljive tablete (57 mg ali 227 mg) so na voljo v naslednjih pakiranjih:
English: These reactions are generally of a transitory nature and are reversible when the treatment is stopped.
Slovenian: Te reakcije so običajno prehodnega značaja in minejo, ko prenehamo z zdravljenjem.
English: Mode of action:
Slovenian: Način delovanja:
English: The peak concentration (Cmax) is 0.52 (± 0.22) µg/ml (equivalent to approximately 1.5 µM), area under the curve (AUC 0-24) is 4.63 (±1.91) µg x hr/ml, and oral bioavailability is 36.9 (± 20.4) percent.
Slovenian: Najvišja vrednost koncentracije (Cmax) je 0,52 (± 0,22) µg/ml (kar ustreza približno 1,5 µM), površina pod krivuljo (AUC 0-24) je 4,63 (± 1,91) µg xhr/ml, in oralna biorazpoložljivost je 36,9 (± 20,4) %.
English: For oral use as per table below.
Slovenian: Za peroralno uporabo v skladu s spodaj navedeno tabelo.
English: Lactose Monohydrate Microcrystalline Cellulose Chartor Hickory Smoke Flavour Hydroxypropyl Cellulose Croscarmellose Sodium Magnesium Stearate Caramel (E150d) Silica, colloidal anhydrous Iron Oxides (E172)
Slovenian: Laktoza monohidrat Celuloza, mikrokristalna Chartor dimni hikori okus Hidroksipropilceluloza Natrijev karmelozat, premreženi Magnezijev stearat Kramel (E150d)
English: Cyclooxygenase is responsible for generation of prostaglandins.
Slovenian: Ciklooksigenaza je odgovorna za sintezo prostaglandinov.
English: 5 mg/kg once daily.
Slovenian: Enkrat dnevno 5 mg/kg.
English: Do not use in animals suffering from gastrointestinal bleeding, blood dyscrasia or haemorrhagic disorders.
Slovenian: Ne uporabite pri živalih s krvavitvami v prebavilih, z motnjami v sestavi krvi ali hemoragičnimi obolenji.
English: 5.2 Pharmacokinetic particulars
Slovenian: 5.2 Farmakokinetične lastnosti
English: Previcox tablets are supplied in blisters (transparent PVC /aluminium foil) or in 30 ml or 100 ml high density polyethylene bottles (with polypropylene closure).
Slovenian: Previcox tablete so v pretisnih omotih (prozorni PVC/aluminijasta folija) - ali 30 ml in 100 ml polietilenskih plastičnih vsebnikih (s polipropilenskim pokrovom).
English: Concomitant treatment with molecules displaying action on renal flow, e.g. diuretics or Angiotensin Converting Enzyme (ACE) inhibitors, should be subject to clinical monitoring.
Slovenian: Sočasno zdravljenje z molekulami, ki vplivajo na pretok skozi ledvice npr. diuretiki ali inhibitorji angiotenzin konvertaze (ACE), mora biti pod strogim veterinarskim nadzorom.
English: For the reduction of post-operative pain and inflammation, the animals can be dosed starting approximately 2 hours before surgery for up to 3 consecutive days as needed.
Slovenian: Za zmanjšanje post-operativne bolečine in vnetja lahko damo živalim prvi odmerek približno 2 uri pred operativnim posegom in po potrebi nadaljujemo zdravljenje še do 3 zaporedne dni.
English: Following orthopaedic surgery and depending on the response observed, treatment using the same daily dosing schedule may be continued after the first 3 days, upon judgement of the attending veterinarian.
Slovenian: Po ortopedskih operativnih posegih lahko, glede na opaženo uspešnost zdravljenja bolečine, enako odmerjanje nadaljujemo tudi po prvih treh dneh po posegu po presoji odgovornega veterinarja.
English: Do not use in animals less than 10 weeks of age or less than 3 kg body weight.
Slovenian: Ne uporabite pri živalih mlajših od 10 tednov in lažjih od 3 kg telesne mase.
English: Following oral administration in dogs at the recommended dose of 5 mg per kg of bodyweight, firocoxib is rapidly absorbed and the time to maximal concentration (Tmax) is 1.25 (± 0.85) hours.
Slovenian: Po peroralnem dajanju zdravila pri psih v priporočenem odmerku 5 mg na kg telesne mase se firokoksib hitro absorbira in v 1,25 (± 0,85) urah doseže maksimalno koncentracijo(Tmax).
English: Firocoxib is metabolised predominantly by dealkylation and glucuronidation in the liver.
Slovenian: Firokoksib se presnavlja večinoma z dealkilizacijo in glukoronidacijo v jetrih.
English: Appropriate laboratory testing is recommended prior to treatment in order to detect subclinical (asymptomatic) renal or hepatic disorders that may predispose to adverse effects.
Slovenian: Pred pričetkom zdravljenja so priporočljive ustrezne laboratorijske preiskave za ugotovitev morebitnih obstoječih subkliničnih (asimptomatskih) ledvičnih ali jetrnih obolenj, ki lahko povečajo možnosti za pojav stranskih učinkov.
English: Administer 5 mg per kg bodyweight once daily as presented in the table below.
Slovenian: Odmerek je 5 mg na kg telesne mase enkrat dnevno kot je prikazano v spodnji tabeli.
English: Following multiple oral administrations, the steady state is reached by the third daily dose.
Slovenian: Po večkratnem peroralnem dajanju doseže ustaljeno stanje s tremi dnevnimi odmerki.
English: Previcox Chewable tablets are scored to facilitate accurate dosing and contain caramel and smoke flavours to facilitate administration to dogs.
Slovenian: Previcox žvečljive tablete omogočajo natančno odmerjanje, okus karamela in dima pa olajša dajanje tablet psom.
English: As with other NSAIDs, serious adverse effects can occur and, in very rare cases, may be fatal.
Slovenian: Kot pri drugih NSAID se lahko pojavijo resni neželeni učinki, ki so izjemoma lahko smrtni.
English: - 1 cardboard box containing 10 tablets in one blister - 1 cardboard box containing 30 tablets in three blisters - 1 cardboard box containing 180 tablets in eighteen blisters - 1 cardboard box containing 60 tablets in one bottle
Slovenian: - 1 škatla z 10 tabletami v enem pretisnem omotu - 1 škatla s 30 tabletami v treh pretisnih omotih - 1 škatla s 180 tabletami v 18 pretisnih omotih - 1 škatla s 60 tabletami
English: Previcox must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Slovenian: Zdravila Previcox ne smete uporabljati skupaj z drugimi NSAID ali glukokortikoidi.
English: The concentration of firocoxib required to inhibit 50 % of the COX-2 enzyme (i.e., the IC50) is 0.16 (± 0.05) µM, whereas the IC50 for COX-1 is 56 (± 7) µM.
Slovenian: 50 odstotno inhibicijo COX-2 encima (t.j IC50) dosežemo s koncentracijo 0,16 (± 0,05) µM firokoksiba, medtem ko IC50 za COX-1 znaša 56 (± 7) µM.
English: As field studies were limited to 90 days, longer-term treatment should be considered carefully and regular monitoring undertaken by the veterinarian.
Slovenian: Ker se podatki raziskav v praksi nanašajo na omejeno obdobje 90 dni, mora biti dolgotrajno zdravljenje pod veterinarskim nadzorom.
English: Coxibs therefore display analgesic, anti-inflammatory and antipyretic properties.
Slovenian: Koksibi imajo protibolečinske, protivnetne in anti piretične lastnosti.
English: In dogs ten weeks of age at the start of treatment at dose rates equal or greater to 25 mg/kg/day (5 times the recommended dose) for three months, the following signs of toxicity were observed: bodyweight loss, poor appetite, changes in the liver (accumulation of lipid), brain (vacuolisation), duodenum (ulcers) and death.
Slovenian: Pri psih, ki so bili ob začetku raziskave stari 10 tednov, so se po treh mesecih prejemanja odmerkov enakih ali višjih od 25 mg/kg/dan (petkratni priporočeni odmerek) pojavila naslednja znamenja toksičnosti: izguba telesne mase, slabši apetit, spremembe v jetrih (nakopičenje lipidov), možganih (vakuolizacija), dvanajstniku (razjede) in pogin živali.
English: Therefore, appropriate laboratory testing to establish baseline renal or hepatic biochemistry parameters is recommended prior to and periodically during administration.
Slovenian: Zato so priporočljive laboratorijske preiskave za določitev osnovnih ledvičnih ali jetrnih biokemijskih vrednosti pred in med dajanjem zdravila.
English: COX-2 is also thought to be involved in ovulation, implantation and closure of the ductus arteriosus, and central nervous system functions (fever induction, pain perception and cognitive function).
Slovenian: COX - 2 naj bi sodeloval tudi pri ovulaciji, implantaciji in zaprtju ductusa arteriosusa, ter pri delovanju centralnega živčnega sistema (sprožitev povišane telesne temperature,
English: EU/2/04/045/001 10 tablets EU/2/04/045/002 30 tablets EU/2/04/045/005 180 tablets EU/2/04/045/008 60 tablets
Slovenian: EU/2/04/045/001 10 tablet EU/2/04/045/002 30 tablet EU/2/04/045/005 180 tablet EU/2/04/045/008 60 tablet
English: It is possible that a proportion of such cases had sub-clinical renal or hepatic disease prior to the commencement of therapy.
Slovenian: Verjetno je del teh živali imel obstoječe subklinične oblike ledvičnih ali jetrnih obolenj pred pričetkom zdravljenja.
English: EU/2/04/045/003 10 tablets EU/2/04/045/004 30 tablets EU/2/04/045/006 180 tablets EU/2/04/045/009 60 tablets
Slovenian: EU/2/04/045/003 10 tablet EU/2/04/045/004 30 tablet EU/2/04/045/006 180 tablet EU/2/04/045/009 60 tablet
English: Tan-brown, round, convex, engraved scored tablets.
Slovenian: Rumeno rjave barve, okrogle, konveksne tablete z vtisnjeno oznako.
English: To be supplied only on veterinary prescription.
Slovenian: Izdaja zdravila je le na veterinarski recept
English: As anaesthetic drugs may affect renal perfusion, the use of parenteral fluids during surgery should be considered to decrease potential renal complications when using NSAIDs peri-operatively.
Slovenian: Ker lahko anestetiki vplivajo na perfuzijo ledvic, je med operativnimi posegi priporočljivo parenteralno nadomeščanje tekočin, da se ob perioperativni uporabi NSAID zmanjša možnost nastanka ledvičnih zapletov.
English: Keep out of the reach and sight of children.
Slovenian: Izogibajte se stiku z očmi in kožo.
English: Concurrent use of other active substances that have a high degree of protein binding may compete with firocoxib for binding and thus lead to toxic effects.
Slovenian: Ob sočasni uporabi drugih zdravilnih učinkovin, ki se dobro vežejo na plazemske proteine, lahko pride do kompetitivnosti pri vezavi s firokoksibom in posledično do toksičnih učinkov.
English: Rarely, nervous system disorders have been reported in treated dogs.
Slovenian: Redko so bile pri zdravljenih psih opisane motnje v delovanju živčnega sistema.
English: If clinical signs of overdosing are observed, discontinue treatment.
Slovenian: Ob pojavu znamenj prekomernega odmerjanja, takoj prenehajte z zdravljenjem.